Project Recommendation

Carbosulfan Sodium injection

Carbosulfan Sodium injection

Time: 2022-02-11  /  View: 1,176 times
Project Recommendation
Information on the reference formulationCommon nameCarbosulfan Sodium injection
Trade NameAdona
English NameCarbosulfan Sodium injection
Dosage formInjection
Specification25mg/5ml,50mg/10ml
HolderニプロESファーマ株式会社
Country of marketingJapan
Features【Pharmacology and Toxicology】

This product can reduce capillary permeability, enhance the retraction of capillary rupture, increase capillary resistance to injury, and is commonly used for a variety of bleeding caused by increased capillary permeability.

IndicationsIt is used for bleeding disorders of the urinary system, upper gastrointestinal tract, respiratory tract and obstetrics and gynaecology. It is also used for the prevention and treatment of surgical bleeding.
Generic drug registration classificationClassified 3 of Chemicals
Project advantages
  • Market advantages: There are no new approved manufacturers in China according to the consistency evaluation requirements of injectables.
  • Compared to other similar drugs, the advantages of this variety are: high stability and easy storage; fast-acting and highly effective.
  • The product can be used in combination with a variety of drugs.
  • Shanghai Baolong has experience in developing mature API and injection research.